CONTENTS
WINTER 2022
Analytics
What’s driving demand for flow cytometry, and what barriers and breakthroughs can be expected in the future?
How are handheld Raman devices and process analysers, implementing Raman spectroscopy, streamlining Quality Control and enabling continuous manufacturing.
Discovery & Development
What has led to the rising trend of cell & gene therapy developers consistently choosing retroviral vectors over other potential vectors – what are the factors driving this decision?
IPT talks to Fiona McLaughlin and Neil Bell of Avacta Therapeutics about the need for cohesion when researching and developing a new drug between life science companies, academia, and medical practitioners.
Johannes Stanta of Celerion speaks to IPT about research into molecular and cellular capabilities, and how they are improving Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards.
IPT talks to Noor Shaker about how digital technology
such as DNA-Encoded Libraries, AI, and machine
learning, can aid research.
such as DNA-Encoded Libraries, AI, and machine
learning, can aid research.
Can AI help researchers when finding the best sites for their clinical trials by utilising Big Data?
Why are more pharma companies choosing to implement blockchain technology when improving data collection and protection?
How will the mass integration of digital tech help the
most underserved countries?
most underserved countries?
Manufacturing
How can the pharma industry ensure quality assurance and control throughout the manufacturing process?
Looking at in-vitro-in silico as an ‘alternative’ pathway for generic inhaled drug products, and how companies should factor in patient variability.
As bioprinting becomes more and more common in the
pharma industry, developers need to better understand regulatory classification.
pharma industry, developers need to better understand regulatory classification.
Regulars
Rounding off 2022 with a reflection on a year of exciting developments in pharmaceutical tech.
46. Events Index
The IPT editorial team looks forward to the best events in the first quarter of 2023.
EXECUTIVE DIRECTOR
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
Iona Everson
EDITORIAL ASSISTANTS
James Spargo
Betsy Goodfellow
EDITORIAL AND PRODUCTION ASSISTANT
Charlie Blackie-Kelly
SALES
Helga Schweissguth
DESIGN
Peter May
FRONT COVER
PopTika – Shutterstock.com
DIGITAL EDITION
by Calaméo
www.calameo.com
CONTACT US
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
PRINTING
Hardings Print Solutions
www.hps-ltd.org.uk
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
Iona Everson
EDITORIAL ASSISTANTS
James Spargo
Betsy Goodfellow
EDITORIAL AND PRODUCTION ASSISTANT
Charlie Blackie-Kelly
SALES
Helga Schweissguth
DESIGN
Peter May
FRONT COVER
PopTika – Shutterstock.com
DIGITAL EDITION
by Calaméo
www.calameo.com
CONTACT US
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
PRINTING
Hardings Print Solutions
www.hps-ltd.org.uk
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables, Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2022 Samedan Ltd
Pharmaceutical Publishers
Curwood CMS Ltd
Unit 9 Barns & Stables, Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2022 Samedan Ltd
Pharmaceutical Publishers
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.